Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Nausea, Vomiting And Quality Of Life Of Patients With Cancer Undergoing Antineoplastic Treatment: An Evaluation By Pharmacists.
Author: de Souza, Cinthia Madeira
Visacri, Marília Berlofa
Ferrari, Graziele Baldan
Tuan, Bruna Taliani
Costa, Anna Paula Lourenço
Barbosa, Cristina Rosa
Lima, Carmen Silvia P
Mazzola, Priscila Gava
Moriel, Patrícia
Abstract: This study aims to evaluate the frequency and severity of nausea and vomiting using two different instruments and relate them to quality of life (QOL) in patients with cancer receiving antineoplastic treatment. Severity of chemotherapy-induced nausea and vomiting (CINV) was measured by Common Terminology Criteria for Adverse Events (CTCAE) and a numerical scale. QOL was assessed using the Functional Assessment of Cancer Therapy-General questionnaire. Of the 50 patients studied, 60.0% reported nausea (40.0% CTCAE grade 1; 66.7% moderate intensity on numerical scale) and 30.0% reported vomiting (46.7% CTCAE grades 1 and 2, each; 66.7% moderate intensity on numerical scale). CINV did not influence overall QOL. The frequency of CINV was high. There was no association between nausea/vomiting and overall QOL.
Subject: Antineoplastic Treatment
Quality Of Life
Rights: fechado
Identifier DOI: 10.1111/ijpp.12169
Date Issue: 2015
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_25572714.pdf189.3 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.